期刊文献+

RSK4蛋白在胰腺癌组织中的表达及意义 被引量:3

EXPRESSION AND CLINICOPATHOLOGICAL SIGNIFICANCE OF RSK4 PROTEIN IN PRIMARY PANCREATIC CARCINOMA TISSUES
下载PDF
导出
摘要 目的:检测核糖体S6蛋白激酶4(Ribosomal S6protein kinase4,RSK4)在胰腺癌组织中的表达,并探讨其与临床病理参数的关系及预后意义。方法:使用免疫组化检测50例胰腺癌及30例癌旁组织中RSK4蛋白的表达,χ2检验和Spearman相关分析其表达与临床病理参数的关系;Kaplan-Meier单因素分析和COX比例风险模型分析患者预后的影响因素。结果:RSK4蛋白在胰腺癌组织中表达率为28%(14/50),癌旁组织中表达率为50%(15/30),胰腺癌组织表达率明显低于癌旁组织(P<0.05)。RSK4蛋白与血清CA199水平有关(r=-0.288,P<0.05),而与其它临床病理参数无关(P>0.05)。RSK4蛋白与患者术后生存期无关(P>0.05);肿瘤分化程度和TNM临床分期是影响胰腺癌患者预后的因素,且均是独立的预后因素。结论:RSK4蛋白在胰腺癌组织中表达水平降低,提示其可能参与胰腺癌的发生发展。 Objective:To investigate the expression and its clinicopathological and prognostic significance of ribosomal S6 protein kinase4(RSK4)protein in human primary pancreatic carcinoma (PC).Methods:Immu-nohistochemical (IHC)staining was performed to detect the expression of RSK4 protein in fifty cases of PC and thirty cases of adj acent non-neoplastic pancreatic tissues.The relationship between RSK4 protein level and clinicopathological parameters of PC were analyzed by Chi-square test and Spearman’s rank correla-tion.Kaplan-Meier univariate analysis and multivariate COX proportional hazards models were used to compare prognostic factors.Results:The relative expression level of RSK4 protein in PC was significantly lower than adjacent non-neoplastic pancreatic tissues (P 〈0.05).The expression of RSK4 protein in PC was reversely related to CA19-9 (r=-0.288,P 〈0.05),however no statistically significant correlation was found between RSK4 protein expression and other clinicopathological parameters and overall survival (P〉0.05).The expressions of tumor differentiation and TNM clinical stage were independent prognostic factors of PC.Conclusion:The down-regulation expression of RSK4 protein in PC reminder RSK4 may play a role in the development of PC.
出处 《广西医科大学学报》 CAS 2015年第1期35-40,共6页 Journal of Guangxi Medical University
基金 国家自然科学基金资助项目(No.81060200)
关键词 胰腺癌 RSK4 免疫组化 预后 immunohistochemistry pancreatic carcinoma prognosis
  • 相关文献

参考文献10

  • 1Lopez-Vicente L, Armengol G, Pons B, et al. Regulation of replieative and stress-induced senescence by RSK4,which is downregulated in human mmors[J]. Clin Cancer Res, 2009,15 (14) : 4 546-4 553.
  • 2付国庆,范林妮,朱瑾,王璐,吕杨,刘一雄,何芙蓉,乔少谊,张磊,邵晨,王哲.Rsk-4蛋白在胰腺肿瘤中的表达及其与临床病理的关系[J].临床与实验病理学杂志,2010,26(6):658-661. 被引量:6
  • 3CaiJ,Ma H,Huang F,et al. Low expression of RSK4 predicts poor prognosis in patients with coIorectai cancer[J]. Int J Clin Exp Pathol,2014,7(8) :4 959-4 970.
  • 4SiegelR,Ma JM,Zou ZH,et al. Cancer Statistics[J]. Cancer J Clin,2014,64:9-29.
  • 5陈万青,张思维,曾红梅,郑荣寿,邹小农,赵平,吴良有,李光琳,赫捷.中国2010年恶性肿瘤发病与死亡[J].中国肿瘤,2014,23(1):1-10. 被引量:882
  • 6Dummler BA, Hauge C,Silber J,et al. Functional char- acterization of human RSK4, a new 90-kDa ri[J]-bosomal 86 kinase, reveals constitutive activation in most cell types. J Biol Chem,2005,280(14):13 304-13 314.
  • 7Lo'pez-Vicente I.,Pons B,Coeh L,et al. RSK4 inhibi tion results in bypass of stress-induced and oncogene induced senescence [J]. Carcinogenesis, 2011,32 (4): 470-476.
  • 8Li Q,Jiang Y,Wei W,et al. Frequent epigenetic inactivation of RSK4 by promoter methylation in cancerous and non-cancerous tissues of breast cancer[J]. Medical Oncology, 2014,31 ( 1 ) : 733.
  • 9Sun Y,Cao S,Yang M,et al. Basic anatomy and tumor biology of the RPS6KA6 gene that encodes the p90 ribosomal S6 kinase-4 [J]. Oncogene, 2013, 32 (14):1 794-1 810.
  • 10谢焕琴,钟武装.血清CA199、CA242及CEA联合检测对胰腺癌的诊断价值[J].广西医科大学学报,2013,30(5):725-726. 被引量:14

二级参考文献18

  • 1吴健民.对肿瘤标志物的再认识[J].中华检验医学杂志,2005,28(1):11-13. 被引量:116
  • 2Thakur A,Xu H,Wang Y,et al.The role of X-linked genes in breast cancer[J].Breast Cancer Res Treat,2005,93(2):135-43.
  • 3Marsh K L,Varley J M.Frequeut alteration of cell cycle regulation in early-stage breast lesions as detected by immunohistochemistry[J].Br J Caner,1998,77(3):1460-8.
  • 4Hayashi M,Feams C,Eliceiri B,et al.Big mitogen-activated protein kinase 1/extracellular signal-regulated kinase 5 signaling pathway is essential for tumor-associated an-giogenesis[J].Cancer Res,2005,65(17):7699-706.
  • 5Yang T T,Xiong Q,Graef I A,et al.Recruitment of the extracellular signal-regulated kinase/ribosomal S6 kinase signaling pathway to the NFATc4 transcription activation complex[J].Mol Cell Biol,2005,25(3):907-20.
  • 6Toledo-Pereyra L H,Lopez-Neblina F,Reuben J S,et al.Selectin inhibition modulates Akt/MAPK signaling and chemokine expression after liver cbemia-reperfusion[J].J Invest Surg,2004,17(6):303-l3.
  • 7Zhang Y,Zhai Q,Luo Y,et al.RANTES-mediated chemokine transcfiption in astrocytes involves activation and translocation of p90 ribosomal S6 protein kinase(RSK)[J].J Biol Chem,2002,277(21):19042-8.
  • 8Richards S A,Dreisbach V C,Murphy L O,et al.Characterization of regulatory events associated with membrane targeting of p90 ribosoreal S6 kinase 1[J].Mol Cell Biol,2001,21(21):7470-80.
  • 9Carriere A,Ray H,Blenis J,et al.The RSK factors of activating the Ras/MAPK signaling cascade[J].Front Biosci,2008,13(10):4258-75.
  • 10Thakur A,Sun Y,Bollig A,et al.Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells[J].Clin Cancer Res,2008,14(14):4427-36.

共引文献899

同被引文献39

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部